Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ghaith Bakdash, Inge Schreurs, Gerty Schreibelt & Jurjen Tel. (2014) Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy. Expert Review of Clinical Immunology 10:7, pages 915-926.
Read now
Read now
Erika Vacchelli, Ilio Vitale, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fučíková, Isabelle Cremer, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:10.
Read now
Read now
Sébastien Anguille, Eva Lion, Johan Van den Bergh, Heleen H Van Acker, Yannick Willemen, Evelien L Smits, Viggo F Van Tendeloo & Zwi N Berneman. (2013) Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy. Human Vaccines & Immunotherapeutics 9:9, pages 1956-1961.
Read now
Read now
Evelien L.J.M. Smits, Sébastien Anguille & Zwi N. Berneman. (2013) Interferon α may be back on track to treat acute myeloid leukemia. OncoImmunology 2:4.
Read now
Read now
Articles from other publishers (21)
Astrid G. S. van Halteren, Jessica S. Suwandi, Sander Tuit, Jelske Borst, Sandra Laban, Roula Tsonaka, Ada Struijk, Anna-Sophia Wiekmeijer, Melissa van Pel, Bart O. Roep, Jaap Jan Zwaginga, Arjan C. Lankester, Koen Schepers, Maarten J. D. van Tol & Willem E. Fibbe. (2023) A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease. Blood 141:11, pages 1277-1292.
Crossref
Crossref
Lea Katharina Picard, Maren Claus, Frank Fasbender & Carsten Watzl. (2022) Human NK cells responses are enhanced by CD56 engagement. European Journal of Immunology 52:9, pages 1441-1451.
Crossref
Crossref
Maarten Versteven, Donovan Flumens, Diana Campillo-Davó, Hans De Reu, Laura Van Bruggen, Stefanie Peeters, Viggo Van Tendeloo, Zwi Berneman, Harry Dolstra, Sébastien Anguille, Willemijn Hobo, Evelien Smits & Eva Lion. (2022) Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands. Frontiers in Immunology 13.
Crossref
Crossref
Taru S. Dutt, Stephanie M. LaVergne, Tracy L. Webb, Bridget A. Baxter, Sophia Stromberg, Kim McFann, Kailey Berry, Madison Tipton, Omar Alnachoukati, Linda Zier, Greg Ebel, Julie Dunn, Marcela Henao-Tamayo & Elizabeth P. Ryan. (2022) Comprehensive Immune Profiling Reveals CD56+ Monocytes and CD31+ Endothelial Cells Are Increased in Severe COVID-19 Disease. The Journal of Immunology 208:3, pages 685-696.
Crossref
Crossref
Asuka Watanabe, Misa Togi, Terutsugu Koya, Makoto Taniguchi, Takuya Sakamoto, Kuniyoshi Iwabuchi, Tomohisa KatoJr.Jr. & Shigetaka Shimodaira. (2021)
Identification of CD56
dim
subpopulation marked with high expression of
GZMB/PRF1/PI‐9
in CD56
+
interferon‐α‐induced dendritic cells
. Genes to Cells 26:5, pages 313-327.
Crossref
Crossref
Arcan Guven, Kayleigh Gray, Kuan-Wei Peng, Allison Klotz, Mark D. Kellogg, Niven R. Narain & Michael A. Kiebish. (2021) Development and validation of an immunoassay for quantification of NCAM-1 in human plasma. Journal of Pharmaceutical and Biomedical Analysis 197, pages 113981.
Crossref
Crossref
Jasper Nörenberg, Pál Jaksó & Alíz Barakonyi. (2021) Gamma/Delta T Cells in the Course of Healthy Human Pregnancy: Cytotoxic Potential and the Tendency of CD8 Expression Make CD56+ γδT Cells a Unique Lymphocyte Subset. Frontiers in Immunology 11.
Crossref
Crossref
Justin T Gunesch, Amera L Dixon, Tasneem AM Ebrahim, Melissa M Berrien-Elliott, Swetha Tatineni, Tejas Kumar, Everardo Hegewisch-Solloa, Todd A Fehniger & Emily M Mace. (2020) CD56 regulates human NK cell cytotoxicity through Pyk2. eLife 9.
Crossref
Crossref
Fan Zou, Lijuan Lu, Jun Liu, Baijin Xia, Wanying Zhang, Qifei Hu, Weiwei Liu, Yiwen Zhang, Yingtong Lin, Shuliang Jing, Mei Huang, Bifen Huang, Bingfeng Liu & Hui Zhang. (2019) Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nature Communications 10:1.
Crossref
Crossref
Heleen H. Van Acker, Zoë P. Van Acker, Maarten Versteven, Peter Ponsaerts, Daniela Pende, Zwi N. Berneman, Sébastien Anguille, Viggo F. Van Tendeloo & Evelien L. Smits. (2019) CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15. Cancers 11:7, pages 1029.
Crossref
Crossref
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F. I. Van Tendeloo, Yiwei Chu, Zwi N. Berneman, Feifei Luo, Heleen H. Van Acker & Sébastien Anguille. (2019) Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen. Frontiers in Immunology 10.
Crossref
Crossref
Ghina Taouk, Ola Hussein, Moussa Zekak, Ali Abouelghar, Yasser Al-Sarraj, Essam M. Abdelalim & Manale Karam. (2019) CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse. Scientific Reports 9:1.
Crossref
Crossref
Maximilian Boesch, Antonio Cosma & Sieghart Sopper. (2018) Flow Cytometry: To Dump or Not To Dump. The Journal of Immunology 201:7, pages 1813-1815.
Crossref
Crossref
Mihwa Kim & Dae Kim. (2018) GFRA1: A Novel Molecular Target for the Prevention of Osteosarcoma Chemoresistance. International Journal of Molecular Sciences 19:4, pages 1078.
Crossref
Crossref
Heleen H. Van Acker, Anna Capsomidis, Evelien L. Smits & Viggo F. Van Tendeloo. (2017) CD56 in the Immune System: More Than a Marker for Cytotoxicity?. Frontiers in Immunology 8.
Crossref
Crossref
Heleen H. Van Acker, Sébastien Anguille, Yannick Willemen, Johan M. Van den Bergh, Zwi N. Berneman, Eva Lion, Evelien L. Smits & Viggo F. Van Tendeloo. (2016) Interleukin-15 enhances the proliferation, stimulatory phenotype, and antitumor effector functions of human gamma delta T cells. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Sebastian Lundgren, Carl Fredrik Warfvinge, Jacob Elebro, Margareta Heby, Björn Nodin, Agnieszka Krzyzanowska, Anders Bjartell, Karin Leandersson, Jakob Eberhard & Karin Jirström. (2016) The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment. PLOS ONE 11:6, pages e0156497.
Crossref
Crossref
Sébastien Anguille, Evelien L. Smits, Christian Bryant, Heleen H. Van Acker, Herman Goossens, Eva Lion, Phillip D. Fromm, Derek N. Hart, Viggo F. Van Tendeloo & Zwi N. Berneman. (2015) Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy. Pharmacological Reviews 67:4, pages 731-753.
Crossref
Crossref
Sébastien Anguille, Heleen H. Van Acker, Johan Van den Bergh, Yannick Willemen, Herman Goossens, Viggo F. Van Tendeloo, Evelien L. Smits, Zwi N. Berneman & Eva Lion. (2015) Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner. PLOS ONE 10:5, pages e0123340.
Crossref
Crossref
Rut Valgardsdottir, Cristina Capitanio, Gemma Texido, Daniela Pende, Claudia Cantoni, Enrico Pesenti, Alessandro Rambaldi, Josée Golay & Martino Introna. (2014) Direct involvement of CD56 in cytokine-induced killer–mediated lysis of CD56+ hematopoietic target cells. Experimental Hematology 42:12, pages 1013-1021.e1.
Crossref
Crossref
Johan M. J. Van den Bergh, Khadija Guerti, Yannick Willemen, Eva Lion, Nathalie Cools, Herman Goossens, Alex Vorsters, Viggo F. I. Van Tendeloo, Sébastien Anguille, Pierre Van Damme & Evelien L. J. M. Smits. (2014)
HPV
vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against
HPV
‐positive tumour cells
. Journal of Cellular and Molecular Medicine 18:7, pages 1372-1380.
Crossref
Crossref